Insights

Innovative Therapeutics OncoOne is actively developing advanced monoclonal antibodies targeting oxMIF for cancer and inflammation, indicating a strong potential for partnerships in biologic therapeutics and diagnostic tools.

Funding & Growth With $14 million in Series A funding and ongoing research initiatives, OncoOne has resources available to expand its product pipeline, offering opportunities for collaborators in clinical development and commercialization.

Recent Collaborations The company's partnership with GenScript ProBio to develop monoclonal antibodies signals openness to external manufacturing and research collaborations, creating avenues for service providers and technology licensors.

Market Focus Specializing in precision medicines for solid tumors and autoimmune diseases, OncoOne presents opportunities for sales of specialty reagents, diagnostic platforms, and therapeutic delivery solutions tailored to oncology and immunology sectors.

Technology Adoption The company's use of advanced research techniques positions them for engaging with vendors offering cutting-edge biotech tools, analytics services, and digital marketing platforms to support their R&D efforts.

OncoOne Tech Stack

OncoOne uses 8 technology products and services including LiteSpeed Cache, RSS, Font Awesome, and more. Explore OncoOne's tech stack below.

  • LiteSpeed Cache
    Caching
  • RSS
    Content Management System
  • Font Awesome
    Font Scripts
  • imagesLoaded
    Javascript Libraries
  • Yoast SEO
    Search Engines
  • Google Tag Manager
    Tag Management
  • Bootstrap
    UI Frameworks
  • Apache HTTP Server
    Web Servers

OncoOne's Email Address Formats

OncoOne uses at least 1 format(s):
OncoOne Email FormatsExamplePercentage
First.Last@oncoone.comJohn.Doe@oncoone.com
50%
First.Last@oncoone.comJohn.Doe@oncoone.com
50%

Frequently Asked Questions

What is OncoOne's official website and social media links?

Minus sign iconPlus sign icon
OncoOne's official website is oncoone.com and has social profiles on LinkedInCrunchbase.

What is OncoOne's SIC code NAICS code?

Minus sign iconPlus sign icon
OncoOne's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does OncoOne have currently?

Minus sign iconPlus sign icon
As of December 2025, OncoOne has approximately 11 employees across 2 continents, including EuropeNorth America. Key team members include Chief Scientific Officer: M. T.Vice President Cmc: F. B.Head Of Finance And Administration: M. R.. Explore OncoOne's employee directory with LeadIQ.

What industry does OncoOne belong to?

Minus sign iconPlus sign icon
OncoOne operates in the Biotechnology Research industry.

What technology does OncoOne use?

Minus sign iconPlus sign icon
OncoOne's tech stack includes LiteSpeed CacheRSSFont AwesomeimagesLoadedYoast SEOGoogle Tag ManagerBootstrapApache HTTP Server.

What is OncoOne's email format?

Minus sign iconPlus sign icon
OncoOne's email format typically follows the pattern of First.Last@oncoone.com. Find more OncoOne email formats with LeadIQ.

How much funding has OncoOne raised to date?

Minus sign iconPlus sign icon
As of December 2025, OncoOne has raised $14M in funding. The last funding round occurred on Mar 18, 2020 for $14M.

When was OncoOne founded?

Minus sign iconPlus sign icon
OncoOne was founded in 2018.

OncoOne

Biotechnology ResearchWien, Austria11-50 Employees

OncoOne is a biotech start-up dedicated to develop innovative therapeutics to treat patients with solid tumors and inflammation.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $14M

    OncoOne has raised a total of $14M of funding over 1 rounds. Their latest funding round was raised on Mar 18, 2020 in the amount of $14M.

  • $1M

    OncoOne's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $14M

    OncoOne has raised a total of $14M of funding over 1 rounds. Their latest funding round was raised on Mar 18, 2020 in the amount of $14M.

  • $1M

    OncoOne's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.